Snowball logo
logo
6031

Zhejiang Shapuaisi Pharmaceutical Co Ltd

603168 SHG
¥5.57¥0.00  (0%)
Estimate
EPS
-0.65
Beta
0.116
Growth
Revenue, YoY
-27.07%
Net income, YoY
250.51%
FCF, YoY
-107.25%
About the company
Ticker
603168
ISIN
CNE100001TG0
Country
China
Sector (GICS)
Healthcare
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. It also offers medical and health care, and scientific research and teaching facilities. Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. was founded in 2000 and is based in Pinghu, China.

Frequently asked questions

What sector does Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) operate in?

Zhejiang Shapuaisi Pharmaceutical Co Ltd belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) current stock price?

As of the latest data, Zhejiang Shapuaisi Pharmaceutical Co Ltd stock price is CN¥5.57, with a previous close of CN¥5.57.

What is Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) current market capitalization?

Zhejiang Shapuaisi Pharmaceutical Co Ltd market cap is approximately 2.08 billion.

What is Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) Earnings Per Share (EPS)?

The trailing EPS is -CN¥0.65.

Does Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) pay dividends?

No. Zhejiang Shapuaisi Pharmaceutical Co Ltd does not pay a dividend.

What is Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) beta (volatility) score?

Zhejiang Shapuaisi Pharmaceutical Co Ltd has a beta of 0.116, indicating lower volatility than the overall market.